XBiotech Property Plant And Equipment Net from 2010 to 2024

XBIT Stock  USD 7.35  0.54  7.93%   
XBiotech Property Plant And Equipment Net yearly trend continues to be comparatively stable with very little volatility. Property Plant And Equipment Net will likely drop to about 22.6 M in 2024. Property Plant And Equipment Net is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects XBiotech's investment in assets used for production. View All Fundamentals
 
Property Plant And Equipment Net  
First Reported
2013-12-31
Previous Quarter
24.9 M
Current Value
24.8 M
Quarterly Volatility
7.9 M
 
Yuan Drop
 
Covid
Check XBiotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XBiotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 985.4 K or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 14.88, Dividend Yield of 0.18 or PTB Ratio of 0.53. XBiotech financial statements analysis is a perfect complement when working with XBiotech Valuation or Volatility modules.
  
Check out the analysis of XBiotech Correlation against competitors.
For more information on how to buy XBiotech Stock please use our How to Invest in XBiotech guide.

Latest XBiotech's Property Plant And Equipment Net Growth Pattern

Below is the plot of the Property Plant And Equipment Net of XBiotech over the last few years. It is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production. XBiotech's Property Plant And Equipment Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in XBiotech's overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Net10 Years Trend
Slightly volatile
   Property Plant And Equipment Net   
       Timeline  

XBiotech Property Plant And Equipment Net Regression Statistics

Arithmetic Mean18,521,698
Geometric Mean13,683,304
Coefficient Of Variation60.12
Mean Deviation10,000,692
Median24,897,000
Standard Deviation11,135,947
Sample Variance124T
Range26.7M
R-Value0.79
Mean Square Error50.6T
R-Squared0.62
Significance0.0005
Slope1,962,737
Total Sum of Squares1736.1T

XBiotech Property Plant And Equipment Net History

202422.6 M
202324.9 M
202226.3 M
202128.3 M
202027.3 M
201925.2 M
201827.3 M

About XBiotech Financial Statements

XBiotech shareholders use historical fundamental indicators, such as Property Plant And Equipment Net, to determine how well the company is positioned to perform in the future. Although XBiotech investors may analyze each financial statement separately, they are all interrelated. The changes in XBiotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on XBiotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Property Plant And Equipment Net24.9 M22.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for XBiotech Stock Analysis

When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.